Several healthcare stocks, including Evolent Health and Humana, experienced declines due to negative developments like analyst downgrades and lost lawsuits. Pharmaceutical and biotech companies also saw drops after unfavorable news, such as Sarepta Therapeutics and GSK. Market concerns about rising costs and pricing for 2025 plans added to the sector’s downward pressure. Evolent Health’s shares have been highly volatile, with significant moves in response to recent news impacting the company’s perceived value. The broader market sentiment has been affected by U.S. trade tensions and policy headwinds aimed at lowering drug prices.

Read more at Barchart: Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know